Colgate-Palmolive (NYSE:CL) Price Target Cut to $96.00 by Analysts at Morgan Stanley

Colgate-Palmolive (NYSE:CLGet Free Report) had its target price lowered by Morgan Stanley from $104.00 to $96.00 in a research note issued to investors on Monday, August 4th, Marketbeat reports. The firm currently has an “overweight” rating on the stock. Morgan Stanley’s target price would indicate a potential upside of 13.33% from the stock’s current price.

Other equities research analysts also recently issued research reports about the stock. UBS Group lowered their target price on shares of Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating for the company in a research note on Thursday, July 17th. JPMorgan Chase & Co. reduced their price target on shares of Colgate-Palmolive from $103.00 to $99.00 and set an “overweight” rating for the company in a report on Friday, July 25th. Wall Street Zen cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Wednesday, May 7th. Wells Fargo & Company reduced their price target on shares of Colgate-Palmolive from $88.00 to $83.00 and set an “underweight” rating for the company in a report on Monday, August 4th. Finally, Barclays upped their price target on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the company an “equal weight” rating in a report on Tuesday, July 15th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $98.92.

Get Our Latest Research Report on CL

Colgate-Palmolive Trading Down 0.0%

Shares of NYSE CL opened at $84.71 on Monday. Colgate-Palmolive has a 1-year low of $82.40 and a 1-year high of $109.30. The company has a market cap of $68.46 billion, a PE ratio of 23.79, a P/E/G ratio of 4.41 and a beta of 0.35. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The company has a 50-day moving average of $88.76 and a two-hundred day moving average of $90.16.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company had revenue of $5.11 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same period in the previous year, the firm posted $0.91 earnings per share. The company’s revenue was up 1.0% on a year-over-year basis. As a group, equities analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Institutional Trading of Colgate-Palmolive

Several hedge funds have recently modified their holdings of the stock. Personal CFO Solutions LLC bought a new stake in Colgate-Palmolive during the 1st quarter valued at $285,000. Vision Capital Management Inc. bought a new stake in Colgate-Palmolive during the 1st quarter valued at $322,000. Autumn Glory Partners LLC increased its stake in Colgate-Palmolive by 67.4% during the 1st quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company’s stock valued at $851,000 after purchasing an additional 3,586 shares in the last quarter. Financial Gravity Asset Management Inc. bought a new stake in Colgate-Palmolive during the 1st quarter valued at $2,166,000. Finally, Summit Investment Advisors Inc. increased its stake in Colgate-Palmolive by 10.8% during the 4th quarter. Summit Investment Advisors Inc. now owns 32,710 shares of the company’s stock valued at $2,974,000 after purchasing an additional 3,187 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

About Colgate-Palmolive

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.